Store-brand products are known to be cheaper, but sometimes, they're also better. These generic items have higher ratings ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...

Emmaus has granted NeoImmuneTech Inc. an exclusive license to all rights to market, sell and distribute Endari and any ...

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into a License and ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

Consumers are being encouraged to abandon pricey branded medicines from chemists, as there's a straightforward method to achieve the same results while spending less money. Flu cases are climbing, ...

Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...

The MarketWatch News Department was not involved in the creation of this content. ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug ...

ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...